Vanda Pharmaceuticals Inc. (VNDA) — DEFA14A Filings
All DEFA14A filings from Vanda Pharmaceuticals Inc.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
Vanda Pharma Files Proxy Supplement
— May 27, 2025 Risk: low
Vanda Pharmaceuticals Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 27, 2025. This filing supplements previous proxy materials. The compa -
Vanda Pharma Files Definitive Additional Proxy Materials
— May 13, 2024 Risk: low
Vanda Pharmaceuticals Inc. is mailing a definitive additional material proxy statement to its stockholders on May 13, 2024. This filing is related to the compan -
Vanda Pharma Mails Stockholder Letter
— May 9, 2024 Risk: low
Vanda Pharmaceuticals Inc. is filing a Definitive Additional Materials proxy statement on May 9, 2024, related to its Schedule 14A filing. This document is a co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX